全基因组关联分析定义了致病信号通路,并优先考虑IgA脏病的药物标
Krzysztof Kiryluk1,2, Elena Sanchez-Rodriguez3, Xu-Jie Zhou4
1Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY, USA. kk473@columbia.edu.
Nature genetics
|June 19, 2023
概括
这项研究确定了30个IgA脏病 (IgAN) 的遗传风险位,这是一种进展性脏疾病. 这些发现突出了炎症途径和IGAN的潜在新药点.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- IgA病 (IgAN) 是一种进展性病,其特征是免疫球蛋白A (IgA) 沉积在淋巴细胞中.
- 了解IgAN的遗传基础对于开发向疗法至关重要.
研究的目的:
- 进行一项大规模的全基因组关联研究 (GWAS),以确定IgA脏病的遗传风险位置.
- 探索已识别的风险位置的功能影响及其与疾病发病和进展的关联.
主要方法:
- 一个GWAS涉及10,146个脏活检诊断的Igan病例和28,751个对照在17个国际队列.
- 统计分析以确定全基因组显著的风险位置,并评估与血清IgA水平的遗传相关性.
- 候选因果基因的功能注释和途径分析.
主要成果:
- 确定了30个全基因组显著的Igan风险位,解释了11%的疾病风险,发现了16个新的位点.
- 风险位点在与小鼠IgA水平异常相关的基因中被丰富,并且在IgAN和血清IgA之间观察到积极的遗传相关性.
- 对Igan的高多基因风险评分与较早发病的功能衰竭有关.
结论:
- 这项研究显著扩大了对IgAN遗传架构的理解,识别了新的风险位置.
- 研究结果表明,在IgAN病变发生过程中,炎症信号通路和细胞因子相互作用是相关的,这表明了潜在的治疗点.
- 对Igan的遗传洞察力为未来研究疾病机制和个性化医学方法提供了基础.
更多相关视频
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
1.8K
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
613
相关概念视频
01:11Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
01:20The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K